A New Way to Fight a Previously 'Inoperable' Pancreatic Cancer

THURSDAY, May 30, 2019 -- A new treatment protocol for locally advanced pancreatic cancer can enable surgical removal of previously inoperable tumors and improve survival rates, according to a new study.

"Locally advanced" pancreatic cancer is confined to the pancreas, but the tumor still involves major abdominal blood vessels and usually cannot be removed by surgery.

Aggressive Uterine Cancer on the Rise, Especially in Blacks: Study

TUESDAY, May 28, 2019 -- There's been a steep uptick in aggressive uterine cancers among American women, especially black women, since 2000, a new study shows.

It also found that black women with these aggressive cancers have lower survival rates than other women.

Blood Test Could Spot Multiple Cancer Types, Researchers Say

WEDNESDAY, May 29, 2019 -- A gene-based blood test can accurately detect breast, colorectal, lung, ovarian, pancreatic, gastric or bile duct cancers in patients, researchers report.

The test uses artificial intelligence to identify and interpret "fragments" of DNA in the blood that indicate the presence of cancer, explained researchers led by Dr. Victor Velculescu. He helps direct the Cancer Biology Program at the Johns Hopkins Kimmel Cancer Center in Baltimore.

Is That Prostate Cancer Worth Treating? Chromosomes May Tell

MONDAY, May 13, 2019 -- To treat, or not to treat: That remains one of the tough conundrums for men with prostate cancer and their doctors, because some tumors may be aggressive, while others may take decades to cause harm.

Now, new research suggests that tracking specific changes in the number of chromosomes inside prostate cancer cells might help solve the riddle.

Not All Cervical Cancer Rates Are Declining

TUESDAY, April 23, 2019 -- A type of cervical cancer that's less sensitive to Pap testing is increasing among white women in the United States, new research shows.

An overall decline in cervical cancer rates in recent decades has been driven by decreases in squamous cell carcinomas. Most of the rest of cervical cancer cases are adenocarcinomas, which are less likely to be detected by Pap testing and are mainly caused by the human papillomavirus (HPV).